Table 1.
Patient demographics, implant device, and surgical data
| Overall | Augmentation cohort | Reconstruction cohort | |
|---|---|---|---|
| Patients, n | 205 | 166 | 39 |
| Implants, n | 385 | 330 | 55 |
| Median age, y | 39 | 35 | 52 |
| Median height, cm | 166 | 168 | 163 |
| Median weight, kg | 57 | 56 | 59 |
| Median BMI, kg/m² | 20 | 20 | 22 |
| Device attributes | |||
| Surface characteristics, n (%) | |||
| Smooth | 18 (8.8%) | 18 (10.8%) | 0 (0%) |
| Textured | 187 (91.2%) | 148 (89.2%) | 39 (100%) |
| Median device size, cc | 280 | 280 | 280 |
| Device placement, n (%) | |||
| Submuscular | 195 (50.6%) | 150 (45.5%) | 45 (81.8%) |
| Subglandular | 179 (46.5%) | 170 (51.5%) | 9 (16.4%) |
| Unreported | 11 (2.9%) | 10 (3.0%) | 1 (1.8%) |
| Surgical approach, n (%) | |||
| Periareolar | 241 (62.6%) | 239 (72.4%) | 2 (3.6%) |
| Inframammary | 64 (16.6%) | 50 (15.2%) | 14 (25.5%) |
| Transaxillary | 32 (8.3%) | 32 (9.7%) | 0 (0%) |
| Mastectomy scar | 37 (9.6%) | 0 (0%) | 37 (67.3%) |
| Other/unreported | 11 (2.9%) | 9 (2.7%) | 2 (3.6%) |
| Smokers, n (%) | 42 (20.5%) | 37 (22.3%) | 5 (12.8%) |
| Preoperative radiotherapy, n (%) | 26 (12.7%) | 1 (0.6%) | 25 (64.1%) |
| Postoperative antibiotics, n (%) | 81 (39.5%) | 45 (27.1%) | 36 (92.3%) |
| Drainage, n (%) | 122 (59.5%) | 86 (51.8%) | 36 (92.3%) |
| Follow-up, months | 63 | 60 | 88 |